Blue Horseshoe Penny Stock Report, CIGX – 08/31/11

Star Scientific, Inc. CIGX

We wanted take a look at CIGX this morning. This is a Nasdaq play that we have discussed in the distant past. In the past, we have witnessed some stellar gains; one of our subscribers even bought himself a house with his windfall profits from CIGX. As we were browsing our records, we took notice of the recent activity, and felt it was high time to re-open the discussion on this stock.

We noticed a significant drop-off that had recently occurred for CIGX, and believe this should be filed under the “rebound play” category.

The company also had a new PR out this morning.

Aug 31, 2011 (AsiaPulse via COMTEX)

Star Scientific Launches Anatabloc(TM) Dietary Supplement

GLEN ALLEN, Va., Aug. 31, 2011 /PRNewswire-AsiaNet/ —

Star Scientific, Inc. (NASDAQ: CIGX) has announced that the company is pleased to initiate the launch today of Anatabloc(TM), a dietary supplement that is designed to support the immune system in maintaining healthy levels of inflammation.

Anatabloc(TM), developed by the company’s Rock Creek Pharmaceuticals subsidiary, is being launched via a dedicated website (http://www.anatabloc.com) where the product can be purchased. The product also can be purchased through a toll-free customer center (1-800-778-2031).

http://www.bayportcorporation.com/

Blue Horseshoe Penny Stock Report – EXTO, – 8/30

Exit Only, Inc. EXTO

We are proud to say that EXTO lit up the boards on Monday. Our alert was almost immediately followed by the announcement that the company would be reducing its number of Authorized Shares by more than 70% EXTO had a slight gap up this morning to a high of .0109, which was followed by a pullback to its support level of .009, where it’s beginning to experience some bounce action.

This consolidation is to be expected after yesterdays nice run; EXTO trades in a predictable manner each time we see a nice surge, there seems to be a period of consolidation where the stock retraces to form a new base at higher levels of support, which we like to see.

Our new level of support is in the .009 range, with resistance at yesterdays high of .011.

EXTO – Penny Stock End-of-Day Report – 8/29

Exit Only, Inc. EXTO

We would be awfully disappointed if no one was able to take advantage of a nice swing that EXTO‘s unbelievable news provoked this morning. The stock was already up 220% since our initial alert, and today that figure was pushed significantly higher. We have extremely high hopes for this gold play, and upon consideration, believe that this could easily be this year’s top performer.

Following our alerts and the huge PR from this morning, EXTO traded more than twice its ten day average and reached a two-weeks previous high of .0105, and it looks as if the new support should come in the penny range. That double top was followed by a push to new highs.

Remember, this company is also slated to start pulling gold from its assay-confirmed mineral-rich claim in October, so now may actually be one of the last chances to see shares at a penny or below.

Exit Only, Inc./Bayport Corporation Announces 71.6% Reduction of Authorized Shares

SANTA MONICA, CA, Aug 29, 2011 (MARKETWIRE via COMTEX) — Exit Only, Inc. (PINKSHEETS: EXTO) today announced that its recently acquired Bayport Corporation, at a directors’ meeting on August 26, 2011, approved an amendment to its Articles of Incorporation reducing the number of Authorized Shares from 3,000,000,000 down to 850,000,000. This change is effective immediately and will be reflecting in the Nevada SOS database shortly.

President of Bayport James L. Porter was quoted as saying, “Reducing the Authorized Shares down by 71.6% should enhance investor confidence while eliminating any illusion of dilution.” In addition, the company has registered with FINRA to commence the process for a name change to Bayport Corporation as well as a new symbol. When these changes are made, the company will apply for a new CUSIP number.

______________________________

Special Announcement: We will be dicussing a brand new play with a primed chart in the morning, so please, don’t miss tomorrow’s report!